A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2006
11/29/2006	CN1868459A Docetaxel freeze-dried powder-injection, and its prepn. method
11/29/2006	CN1868458A Controlled release composition and method of producing the same
11/29/2006	CN1868457A Prepn. method of matrine magnetic micro-ball
11/29/2006	CN1868456A Prepn. of antisense deoxyoligonucleotide ISIS23665 elaioplast, and its prepn. method
11/29/2006	CN1868455A Intravenous nanometer suspension injection contg. oxaliplatin platinum phospholipid compound
11/29/2006	CN1868454A Slow-release injection contg. platinum compounds and its potentiator
11/29/2006	CN1868453A Slow-release injection contg. platinum compounds and cellulotoxic medicines
11/29/2006	CN1868452A Anticancer slow-release injection contg. platinum compounds
11/29/2006	CN1286981C Combination adeno-associated virus of expression human CYP2J2 antigene and its preparation method
11/29/2006	CN1286840C Isopentenyl xanthone compounds and their use in the preparation of antitumor medicines
11/29/2006	CN1286839C Fermentation preparation method of cell inhibitor and its crystal form
11/29/2006	CN1286835C Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/29/2006	CN1286828C Process for preparing paclitaxel
11/29/2006	CN1286821C 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
11/29/2006	CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound
11/29/2006	CN1286810C 2-acyl indol derivatives and their use as anti-tumour agents
11/29/2006	CN1286531C Antisense nucleic acids medicine composition with bcr3/abl2 and VEGF gene function inhibition and use thereof
11/29/2006	CN1286526C Anti-cancer medicine composition
11/29/2006	CN1286510C Medicine for treating tumor and cancer
11/29/2006	CN1286465C Radix salviae miltiorrhizae oligosaccharide and its application for resisting acquired immunodeficiency syndrome, adjusting immunity and increasing leukocyte
11/29/2006	CN1286464C Pharmaceutical composition for protecting liver, preventing and treating liver cancer
11/29/2006	CN1286456C Luolai compositions useful for the treatment of type-2 synalbumin diabetes pharmaceutical application
11/29/2006	CN1286454C Method for preparing controllable complex of taxiol and polylactic acid
11/28/2006	US7141691 Derivatives of carboplatin with fewer undesired side-effects and higher efficacy towards tumor tissue; for treatment of cancer
11/28/2006	US7141661 Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
11/28/2006	US7141651 Multiple cytokine protein complexes
11/28/2006	US7141598 Imidazole derivatives, production method thereof and use thereof
11/28/2006	US7141589 Methods of inhibiting formation of vascular channels and methods of inhibiting proliferation
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141577 Antitumor agents
11/28/2006	US7141576 4-quinazolineamine derivatives; antineoplastic agents; inhibitors of erb family tyrosine kinases and/or epidermal growth factor receptors
11/28/2006	US7141568 Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/28/2006	US7141558 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
11/28/2006	US7141557 Lipid analogs for treating viral infections
11/28/2006	US7141550 Intra-tumoral administration of IL-12 encoding nucleic acid molecules
11/28/2006	US7141547 Albumin fusion proteins comprising GLP-1 polypeptides
11/28/2006	US7141541 Use of peptides
11/28/2006	US7141383 EDG8 receptor, its preparation and use
11/28/2006	US7141363 Purposeful movement of human migratory cells away from an agent source
11/28/2006	US7141262 Using microfiltration and/or diafiltration to isolate transforming growth factor from dairy products for use in treatment and prevention of cell proliferative, autoimmune, bone and inflammatory disorders; antitumor agents
11/28/2006	US7141251 Pharmacologically active strong acid solutions
11/28/2006	US7141233 Radionuclide labeling of vitamin B12 and coenzymes thereof
11/28/2006	CA2375524C 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/28/2006	CA2375513C 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
11/28/2006	CA2305370C Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function
11/28/2006	CA2234609C 2-amino-6-anilino-purine derivatives and processes for their preparation
11/28/2006	CA2155018C C7 taxane derivatives and pharmaceutical compositions containing them
11/28/2006	CA2137203C Protein kinase c inhibitors
11/28/2006	CA2026915C Stem cell factor
11/23/2006	WO2006124996A2 Inhibitors of polo-like kinase-1
11/23/2006	WO2006124874A2 Inhibitors of b-raf kinase
11/23/2006	WO2006124863A2 Pyrrolopyridine derivatives as protein kinase inhibitors
11/23/2006	WO2006124737A2 Molecular constructs suitable for targeted conjugates
11/23/2006	WO2006124731A2 Compounds and compositions as protein kinase inhibitors
11/23/2006	WO2006124689A2 Combination therapy
11/23/2006	WO2006124462A2 Compounds and compositions as protein kinase inhibitors
11/23/2006	WO2006123829A1 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
11/23/2006	WO2006123724A1 Novel pharmaceutical using anti-hla antibody
11/23/2006	WO2006123644A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF
11/23/2006	WO2006123618A1 Oxidative stress inhibitor
11/23/2006	WO2006123466A1 Drugs, food or drink for improving pancreatic functions
11/23/2006	WO2006123185A2 Sulphamides for treatment of cancer
11/23/2006	WO2006123183A2 Sulphone derivatives for treatment of cancer
11/23/2006	WO2006123182A2 Cyclohexyl sulphones for treatment of cancer
11/23/2006	WO2006123122A2 Psk- i and its modulators for the treatment/diagnosis of cancer
11/23/2006	WO2006123121A1 Histone deacetylase inhibitors
11/23/2006	WO2006123113A2 Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
11/23/2006	WO2006123061A2 Fluorene derivatives, composition containing said derivatives and the use thereof
11/23/2006	WO2006122954A2 Antiproliferative conjugates comprising hyaluronic acid and n-derivatives of glutamic acid
11/23/2006	WO2006122926A1 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
11/23/2006	WO2006122914A2 Medicament, particularly an anti-cancer medicament, for treatment using immunotherapy, particularly autologous
11/23/2006	WO2006122910A1 Halogenated quindoline dimers for the treatment of cancer
11/23/2006	WO2006122806A2 1,3-dihydro-imidazo [4,5-c] quinolin-2-ones as lipid kinase inhibitors
11/23/2006	WO2006122680A1 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2)
11/23/2006	WO2006122464A1 An oligonucleotide or its functional homologue, a composition comprising the same and a method for treating b cell neoplasm
11/23/2006	WO2006122463A1 Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating b cell neoplasm
11/23/2006	WO2006122431A1 Triazine compounds and compositions thereof for the treatment of cancers
11/23/2006	WO2006122408A1 Bir domain binding compounds
11/23/2006	WO2006110175A9 Combined treatment with bortezomib and an epidermal growth factor receptor kinase inhibitor
11/23/2006	WO2006108155A3 Process for the preparation of anastrozole
11/23/2006	WO2006106437A3 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
11/23/2006	WO2006094828A3 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor
11/23/2006	WO2006092230A3 Protein-binding camptothecin peptide derivatives and medicaments comprising the same
11/23/2006	WO2006084015A3 Raf inhibitor compounds and methods
11/23/2006	WO2006067465A3 Cancer treatment
11/23/2006	US20060265763 Dyrks as modifiersof the apc and axin pathways and methods of use
11/23/2006	US20060264627 Heterocyclic hydrazones as novel anti-cancer agents
11/23/2006	US20060264626 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE
11/23/2006	US20060264609 Use of heat shock proteins
11/23/2006	US20060264514 4-oxo-fenretinide, administered alone and in combination with fenretinide, as preventive and therapeutic agent for cancer
11/23/2006	US20060264502 Agent for treatment of cisplatin-resistant cancer
11/23/2006	US20060264501 For parenteral administration containing oxaliplatin, water; and an acid, especially a di- or tricarboxylic acid such as tartaric acid or a sodium tartrate as a buffering agent that minimises significant degradation of oxaliplatin and limits the formation of unwanted impurities; cancer treatment
11/23/2006	US20060264493 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/23/2006	US20060264492 methyl [5(6)-(4-alanylaminophenylthio)-1H-benzimidazol-2yl]carbamate; for treating neovascularization, solid tumors, macular degeneration, diabetic retinopathy, rheumatoid arthritis, psoriasis, and atherosclerosis
11/23/2006	US20060264482 Epothilones C, D, E and F, preparation and compositions
11/23/2006	US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors
11/23/2006	US20060264477 Methods of using cyclic amides
11/23/2006	US20060264464 Amidino compounds as cysteine protease inhibitors
11/23/2006	US20060264456 Phosphorus-containing compounds & uses thereof
11/23/2006	US20060264450 Such as (S)-4-[(3-chloro-4-fluoro-phenyl)amino]-6-[2-(2-oxo-5-methyl-oxazolidin-3-yl)ethyloxy]-7-methoxy-quinazoline; inhibiting signal transduction by tyrosine kinases; treating tumoral diseases and benign prostatic hyperplasia, and diseases of lungs and respiratory tract

1 ... 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 ... 2211